Description

Letrovista Coated Tablets 2.5 mg.

Letrovista coated tablets are a medication used in the treatment of certain types of breast cancer. Each tablet contains 2.5 mg. of the active ingredient, letrozole. Letrozole belongs to a class of medications known as aromatase inhibitors, which work by reducing the production of estrogen in the body. This can help slow or stop the growth of certain types of breast tumors that require estrogen to grow.

Indications

Letrovista coated tablets are indicated for the treatment of postmenopausal women with hormone receptor-positive early breast cancer.

Dosage and Administration

The usual dose of Letrovista coated tablets is 2.5 mg. taken once daily, with or without food. It is important to take the medication at the same time each day to maintain consistent levels in the body. The duration of treatment will vary depending on the individual’s response to the medication and the stage of breast cancer being treated. It is important to follow your healthcare provider’s instructions regarding the dosing and duration of treatment.

Precautions

Before taking Letrovista coated tablets, inform your healthcare provider if you have a history of liver disease, osteoporosis, or if you are pregnant or breastfeeding. Letrozole may cause harm to an unborn baby, so it is important to use effective contraception during treatment and avoid becoming pregnant. Letrozole may also affect bone mineral density, so your healthcare provider may monitor your bone health during treatment.

Side Effects

Common side effects of Letrovista coated tablets may include hot flashes, fatigue, joint pain, and nausea. If you experience any severe or persistent side effects, contact your healthcare provider. In rare cases, letrozole may cause more serious side effects such as bone fractures, blood clots, or liver problems. It is important to report any unusual symptoms to your healthcare provider.

Interactions

Letrovista coated tablets may interact with other medications, including hormone replacement therapy, tamoxifen, and certain antidepressants. Inform your healthcare provider of all medications you are taking, including prescription, over-the-counter, and herbal supplements, to avoid potential drug interactions.

Storage

Store Letrovista coated tablets at room temperature, away from moisture and heat. Keep the medication out of reach of children and pets. Do not use Letrovista coated tablets after the expiration date printed on the packaging.

Conclusion

Letrovista coated tablets are a valuable medication used in the treatment of postmenopausal women with hormone receptor-positive early breast cancer. By inhibiting estrogen production in the body, letrozole can help slow or stop the growth of certain types of breast tumors. It is important to take Letrovista coated tablets as directed by your healthcare provider and to report any unusual symptoms or side effects. With proper precautions and monitoring, Letrovista coated tablets can be an effective treatment option for individuals with hormone receptor-positive early breast cancer.